Consolidating Antibody Discovery Data with an AI Platform
The Sapio Scientific AI platform gives scientists a single, structured environment where experimental records connect directly to client deliverables and where time spent on data consolidation becomes time spent on science. The post Consolidating Antibody Discovery Data with an AI Platform appeared first on GEN - Genetic Engineering and Biotechnology News .
FairJourney Bio (FJBio), a global antibody discovery partner established in 2012, has chosen the Sapio Scientific AI platform to streamline its research operations. The platform, which includes Sapio’s Laboratory Information Management System (LIMS), Electronic Laboratory Notebook (ELN), and AI co-scientist named Elain, will replace FJBio’s current spreadsheet-based records and manual reporting processes across its three centers of excellence in Porto (Portugal), Cambridge (U.K.), and San Diego (U.S.).
Sapio’s LIMS will serve as a single entity registry, managing data from target registration through clone identification and screening results across all programs. This intuitive system will eliminate the need for scientists to manually input data from paper templates into spreadsheets, streamlining the data management process. Additionally, the LIMS is designed to integrate directly with lab instruments, connecting instrument output to Sapio’s experiment records and eliminating the need for manual transcription at the bench.
Elain, Sapio’s native AI co-scientist, will bring intelligence to FJBio’s scientific workflows. Working within the structured experimental data held within the Sapio Platform, Elain enables scientists to interact with their data using natural language, eliminating the need to leave the environment where experiments, samples, and results are managed. The inclusion of Elain, rather than an optional add-on, was a key differentiator for FJBio in selecting the platform for its long-term informatics capabilities.
FJBio’s COO, José Vidal, emphasizes the importance of an informatics platform that can keep pace with the growing operations across multiple international sites. The Sapio Platform provides FJBio with a single connected environment for every experiment, sample, and result, ensuring that time spent on data consolidation becomes time spent on scientific discovery.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
